Literature DB >> 1249521

Subversion of host defense mechanisms by murine tumors. II. Counter-influence of concomitant antitumor immunity.

R J North, D P Kirstein, R L Tuttle.   

Abstract

Subcutaneous injection of murine tumor cells first resulted in a state of severely suppressed macrophage-mediated antibacterial resistance and then in a contrasting state of greatly enhanced antibacterial resistance. Whereas, the state of suppressed antibacterial resistance corresponded to a state of suppressed resistance to a tumor cell challenge, the generation of enhanced antibacterial resistance corresponded to the acquisition of concomitant antitumor immunity. It was suggested on the basis of this evidence that changes in the level of macrophage-mediated antibacterial resistance that occur during growth of the primary tumor reflected changes in the level of the host's resistance to the tumor itself. It was further suggested that the coincidental suppression of antibacterial and antitumor resistance that occurs during the initial stages of growth of the primary tumor represents the operation of a mechanism that enables the tumor to avoid destruction by macrophages. The results support the view that macrophages play an important role in native and acquired resistance to malignant tumors.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1249521      PMCID: PMC2190144          DOI: 10.1084/jem.143.3.574

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice.

Authors:  M C Fioretti; M Libarati; E Bonmassar; G Cudkowicz
Journal:  Cancer Res       Date:  1975-01       Impact factor: 12.701

2.  The reticuloendothelial system and the neoplastic process.

Authors:  L J OLD; D A CLARKE; B BENACERRAF; M GOLDSMITH
Journal:  Ann N Y Acad Sci       Date:  1960-06-21       Impact factor: 5.691

3.  Mechanisms by which activated normal macrophages destroy syngeneic rat tumour cells in vitro. Cytokinetics, non-involvement of T lymphocytes, and effect of metabolic inhibitors.

Authors:  R Keller
Journal:  Immunology       Date:  1974-08       Impact factor: 7.397

4.  In vitro nonimmunologic destruction of cells with abnormal growth characteristics by adjuvant activated macrophages.

Authors:  J B Hibbs; L H Lambert; J S Remington
Journal:  Proc Soc Exp Biol Med       Date:  1972-03

5.  Reticulo-endothelial activity in humans with cancer.

Authors:  C J Magarey; M Baum
Journal:  Br J Surg       Date:  1970-10       Impact factor: 6.939

6.  Specific and nonspecific antitumor immunity. II. Macrophage-mediated nonspecific effector activity induced by BCG and similar agents.

Authors:  R N Germain; R M Williams; B Benacerraf
Journal:  J Natl Cancer Inst       Date:  1975-03       Impact factor: 13.506

7.  Delayed lethal response to Candida albicans infection in mice bearing the Lewis lung carcinoma.

Authors:  E H Robinette; D N Mardon
Journal:  J Natl Cancer Inst       Date:  1975-09       Impact factor: 13.506

8.  Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.

Authors:  R Kearney; A Basten; D S Nelson
Journal:  Int J Cancer       Date:  1975-03-15       Impact factor: 7.396

  8 in total
  12 in total

Review 1.  Acute inflammation. A review.

Authors:  G B Ryan; G Majno
Journal:  Am J Pathol       Date:  1977-01       Impact factor: 4.307

Review 2.  Disordered function of mononuclear phagocytes in malignant disease.

Authors:  R J Sokol; G Hudson
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

Review 3.  Macrophages: progress and problems.

Authors:  D S Nelson
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

4.  Alterations of host resistance to Listeria monocytogenes in tumour-bearing mice and the effect of Corynebacterium parvum.

Authors:  H Miyata; K Himeno; S Miake; K Nomoto
Journal:  Immunology       Date:  1981-10       Impact factor: 7.397

5.  Correlation between in vivo and in vitro functional tests for activated macrophages.

Authors:  J M Rhodes; J Bennedsen; S O Larsen; S Riisgaard; J V Spärck
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

6.  The induction of human peripheral blood lymphoid colonies by conditioned media from human tumour cell lines.

Authors:  D H Vesole; G E Moore
Journal:  Immunology       Date:  1980-11       Impact factor: 7.397

7.  Effect of L1210 leukemia on the susceptibility of mice to Candida albicans infections.

Authors:  J A Johnson; B H Lau; R L Nutter; J M Slater; C E Winter
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

8.  Immune reactivity in SL2 lymphoma-bearing mice compared with SL2-immunized mice.

Authors:  R A De Weger; B Wilbrink; R M Moberts; D Mans; R Oskam; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

9.  T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites.

Authors:  R J North; D P Kirstein
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

10.  Subversion of host defense mechanisms by malignant tumors: an established tumor as a privileged site for bacterial growth.

Authors:  G L Spitalny; R J North
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.